These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 16206076

  • 1. Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis.
    Cirioni O, Giacometti A, Ghiselli R, Kamysz W, Orlando F, Mocchegiani F, Silvestri C, Licci A, Łukasiak J, Saba V, Scalise G.
    J Infect Dis; 2005 Nov 01; 192(9):1613-20. PubMed ID: 16206076
    [Abstract] [Full Text] [Related]

  • 2. RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis.
    Ghiselli R, Giacometti A, Cirioni O, Dell'Acqua G, Bergnach C, Orlando F, Mocchegiani F, Silvestri C, Skerlavaj B, Licci A, Balaban N, Zanetti M, Scalise G, Saba V.
    Shock; 2006 Sep 01; 26(3):296-301. PubMed ID: 16912656
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria.
    Giacometti A, Cirioni O, Ghiselli R, Mocchegiani F, Orlando F, Silvestri C, Bozzi A, Di Giulio A, Luzi C, Mangoni ML, Barra D, Saba V, Scalise G, Rinaldi AC.
    Antimicrob Agents Chemother; 2006 Jul 01; 50(7):2478-86. PubMed ID: 16801429
    [Abstract] [Full Text] [Related]

  • 7. The antimicrobial peptide BMAP-28 reduces lethality in mouse models of staphylococcal sepsis.
    Giacometti A, Cirioni O, Ghiselli R, Bergnach C, Orlando F, D'Amato G, Mocchegiani F, Silvestri C, Del Prete MS, Skerlavaj B, Saba V, Zanetti M, Scalise G.
    Crit Care Med; 2004 Dec 01; 32(12):2485-90. PubMed ID: 15599155
    [Abstract] [Full Text] [Related]

  • 8. Experimental study on the efficacy of combination of alpha-helical antimicrobial peptides and vancomycin against Staphylococcus aureus with intermediate resistance to glycopeptides.
    Cirioni O, Silvestri C, Ghiselli R, Giacometti A, Orlando F, Mocchegiani F, Chiodi L, Vittoria AD, Saba V, Scalise G.
    Peptides; 2006 Nov 01; 27(11):2600-6. PubMed ID: 16797106
    [Abstract] [Full Text] [Related]

  • 9. Antibiotic treatment in a murine model of sepsis: impact on cytokines and endotoxin release.
    Vianna RC, Gomes RN, Bozza FA, Amâncio RT, Bozza PT, David CM, Castro-Faria-Neto HC.
    Shock; 2004 Feb 01; 21(2):115-20. PubMed ID: 14752283
    [Abstract] [Full Text] [Related]

  • 10. Temporin A is effective in MRSA-infected wounds through bactericidal activity and acceleration of wound repair in a murine model.
    Simonetti O, Cirioni O, Goteri G, Ghiselli R, Kamysz W, Kamysz E, Silvestri C, Orlando F, Barucca C, Scalise A, Saba V, Scalise G, Giacometti A, Offidani A.
    Peptides; 2008 Apr 01; 29(4):520-8. PubMed ID: 18255189
    [Abstract] [Full Text] [Related]

  • 11. Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock.
    Giacometti A, Cirioni O, Ghiselli R, Orlando F, Kamysz W, Rocchi M, D'Amato G, Mocchegiani F, Silvestri C, Łukasiak J, Saba V, Scalise G.
    Peptides; 2005 Feb 01; 26(2):207-16. PubMed ID: 15629532
    [Abstract] [Full Text] [Related]

  • 12. The combination of a tumor necrosis factor inhibitor and antibiotic alleviates staphylococcal arthritis and sepsis in mice.
    Fei Y, Wang W, Kwiecinski J, Josefsson E, Pullerits R, Jonsson IM, Magnusson M, Jin T.
    J Infect Dis; 2011 Aug 01; 204(3):348-57. PubMed ID: 21742832
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat Pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides.
    Cirioni O, Giacometti A, Ghiselli R, Dell'Acqua G, Gov Y, Kamysz W, Lukasiak J, Mocchegiani F, Orlando F, D'Amato G, Balaban N, Saba V, Scalise G.
    Circulation; 2003 Aug 12; 108(6):767-71. PubMed ID: 12885754
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Shrimp (Penaeus monodon) anti-lipopolysaccharide factor reduces the lethality of Pseudomonas aeruginosa sepsis in mice.
    Pan CY, Chao TT, Chen JC, Chen JY, Liu WC, Lin CH, Kuo CM.
    Int Immunopharmacol; 2007 May 12; 7(5):687-700. PubMed ID: 17386416
    [Abstract] [Full Text] [Related]

  • 18. RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections.
    Cirioni O, Giacometti A, Ghiselli R, Dell'Acqua G, Orlando F, Mocchegiani F, Silvestri C, Licci A, Saba V, Scalise G, Balaban N.
    J Infect Dis; 2006 Jan 15; 193(2):180-6. PubMed ID: 16362881
    [Abstract] [Full Text] [Related]

  • 19. Protection of Staphylococcus aureus-infected septic mice by suppression of early acute inflammation and enhanced antimicrobial activity by ginsan.
    Ahn JY, Song JY, Yun YS, Jeong G, Choi IS.
    FEMS Immunol Med Microbiol; 2006 Mar 15; 46(2):187-97. PubMed ID: 16487300
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.